You are here
- Home
- Total number of clinical trials
A Double-blind, Placebo-controlled, Randomized Study in Rheumatoid Arthritis Subjects to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Doses of MEDI5117 (anti-IL-6).
- Disease
- rheumatoid arthritis
- Drug Name
- AstraZeneca Neuroscience Development Drugs
- Generic Name
- MEDI 5117
- Sponsor
- AstraZeneca
- Drug Status
- In Development
- Phase
- I
- Start Date
- Jan 18, 1971
- Study Name
- D4430C00001
- Study Id
- D4430C00001
- ClinicalTrials.gov ID
- NCT01559103
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
